<ARTICLE> 5 <LEGEND> THE SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM CONDENSED CONSOLIDATED BALANCE SHEETS, CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS REPORTED IN FORM 10-Q FOR THE PERIOD ENDED OCTOBER 1, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS. </LEGEND> <CIK> 0000925054 <NAME> SPECTRIAN CORP /DE/ <MULTIPLIER> 1,000 <PERIOD-TYPE> 6-MOS <FISCAL-YEAR-END> MAR-31-2001 <PERIOD-START> APR-01-2000 <PERIOD-END> OCT-01-2000 <CASH> 16,011 <SECURITIES> 28,211 <F1> <RECEIVABLES> 24,418 <ALLOWANCES> 420 <INVENTORY> 28,059 <CURRENT-ASSETS> 104,433 <PP&E> 69,652 <DEPRECIATION> 51,187 <TOTAL-ASSETS> 124,166 <CURRENT-LIABILITIES> 29,822 <BONDS> 573 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 12 <OTHER-SE> 93,759 <TOTAL-LIABILITY-AND-EQUITY> 124,166 <SALES> 84,106 <TOTAL-REVENUES> 84,106 <CGS> 69,982 <TOTAL-COSTS> 69,982 <OTHER-EXPENSES> 10,942 <F2> <LOSS-PROVISION> 0 <INTEREST-EXPENSE> 89 <INCOME-PRETAX> (7,653) <INCOME-TAX> 12 <INCOME-CONTINUING> (7,665) <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> (7,665) <EPS-BASIC> (0.70) <F3> <EPS-DILUTED> (0.70) <FN> <F1> Securities, Item 5-02(2), are net of accrued interest and unrealized gain/loss. <F2> Item consists of research and development. <F3> Item consists of basic earnings per share. </FN>